Araştırma Makalesi
BibTex RIS Kaynak Göster

Revalence of hepatitis c virus antibody in cancer patients from turkey

Yıl 1994, Cilt: 7 Sayı: 1, 14 - 17, 01.01.1994

A. Topeli Ö. Özyılkan E. Özyıllcan A. Kars G. Tekuzman E. Baltalı B. Kayhan H. Telatar D. Fırat

Öz

We investigated the frequency of Hepatitis C Virus antibodies (anti - HCV), using 2nd generation Enzyme Linked Immunosorbent Assay (ELISA - Abbott Laboratories), in 83 cancer patients (54 males, 29 females) with a mean age of 48.2 years (range 17 - 82). Of the 83 patients, 11 (13.2 %) were positive for anti - HCV and this frequency was higher than the prevalence of 0.0 % - 0.6 % reported for the normal Turkish population. The history of blood transfusion (72.7 % vs 37.5 %), operation (45.4 % vs 30.5 %) and hepatitis (9.0 % vs 8.3 %) were more frequent in the group with HCV antibody compared to the group without HCV antibody, but the differences were not statistically significant (p> 0.05). The frequency of elevated alanine aminotransferase (1.5 times upper limit of normal) was higher in anti - HCV positive patients compared to patients without anti - HCV antibody (p=0.0015). Our results indicate that cancer patients are vulnerable to HCV infection.

Anahtar Kelimeler

Hepatitis C Virus - Cancer Patients

Kaynakça

  • Seeff LB, Dienstag JL. Transfusion-associated non-A, non-B hepatitis-Where do we go from here? Qastroenterology 1988:95:530-533.

Yıl 1994, Cilt: 7 Sayı: 1, 14 - 17, 01.01.1994

A. Topeli Ö. Özyılkan E. Özyıllcan A. Kars G. Tekuzman E. Baltalı B. Kayhan H. Telatar D. Fırat

Öz

Kaynakça

  • Seeff LB, Dienstag JL. Transfusion-associated non-A, non-B hepatitis-Where do we go from here? Qastroenterology 1988:95:530-533.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Konular Klinik Tıp Bilimleri
Bölüm Derleme
Yazarlar

A. Topeli Bu kişi benim

Ö. Özyılkan Bu kişi benim

E. Özyıllcan Bu kişi benim

A. Kars Bu kişi benim

G. Tekuzman Bu kişi benim

E. Baltalı Bu kişi benim

B. Kayhan Bu kişi benim

H. Telatar Bu kişi benim

D. Fırat Bu kişi benim

Yayımlanma Tarihi 1 Ocak 1994
Yayımlandığı Sayı Yıl 1994 Cilt: 7 Sayı: 1

Kaynak Göster

APA Topeli, A., Özyılkan, Ö., Özyıllcan, E., Kars, A., vd. (1994). Revalence of hepatitis c virus antibody in cancer patients from turkey. Marmara Medical Journal, 7(1), 14-17.
AMA Topeli A, Özyılkan Ö, Özyıllcan E, Kars A, Tekuzman G, Baltalı E, Kayhan B, Telatar H, Fırat D. Revalence of hepatitis c virus antibody in cancer patients from turkey. Marmara Med J. Ocak 1994;7(1):14-17.
Chicago Topeli, A., Ö. Özyılkan, E. Özyıllcan, A. Kars, G. Tekuzman, E. Baltalı, B. Kayhan, H. Telatar, ve D. Fırat. “Revalence of Hepatitis C Virus Antibody in Cancer Patients from Turkey”. Marmara Medical Journal 7, sy. 1 (Ocak 1994): 14-17.
EndNote Topeli A, Özyılkan Ö, Özyıllcan E, Kars A, Tekuzman G, Baltalı E, Kayhan B, Telatar H, Fırat D (01 Ocak 1994) Revalence of hepatitis c virus antibody in cancer patients from turkey. Marmara Medical Journal 7 1 14–17.
IEEE A. Topeli, “Revalence of hepatitis c virus antibody in cancer patients from turkey”, Marmara Med J, c. 7, sy. 1, ss. 14–17, 1994.
ISNAD Topeli, A. vd. “Revalence of Hepatitis C Virus Antibody in Cancer Patients from Turkey”. Marmara Medical Journal 7/1 (Ocak 1994), 14-17.
JAMA Topeli A, Özyılkan Ö, Özyıllcan E, Kars A, Tekuzman G, Baltalı E, Kayhan B, Telatar H, Fırat D. Revalence of hepatitis c virus antibody in cancer patients from turkey. Marmara Med J. 1994;7:14–17.
MLA Topeli, A. vd. “Revalence of Hepatitis C Virus Antibody in Cancer Patients from Turkey”. Marmara Medical Journal, c. 7, sy. 1, 1994, ss. 14-17.
Vancouver Topeli A, Özyılkan Ö, Özyıllcan E, Kars A, Tekuzman G, Baltalı E, Kayhan B, Telatar H, Fırat D. Revalence of hepatitis c virus antibody in cancer patients from turkey. Marmara Med J. 1994;7(1):14-7.